This inventor holds 1 USPTO granted patent. Top assignee: Technion Research & Development Foundation Ltd. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Yamen Abu Ahmad: Innovator in RNF4 Targeting Compounds
Introduction
Yamen Abu Ahmad is a notable inventor based in Haifa, Israel. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds targeting RNF4-related disorders. His innovative work has the potential to impact the treatment and prevention of various health conditions.
Latest Patents
Yamen holds a patent for RNF4 targeting compounds and their uses. The present invention provides compounds and pharmaceutical compositions comprising thereof. Furthermore, methods for treating or preventing the development of an RNF4-related disorder in a subject in need thereof are also included in his patent. This patent highlights his commitment to advancing medical science and improving patient outcomes.
Career Highlights
Yamen Abu Ahmad is associated with the Technion Research & Development Foundation Ltd. His work at this esteemed institution has allowed him to collaborate with other talented researchers and contribute to groundbreaking innovations in the field of pharmaceuticals.
Collaborations
Some of Yamen's notable coworkers include Amir Oryan and Ashraf Brik. Their collaborative efforts have fostered an environment of innovation and creativity, leading to advancements in their respective fields.
Conclusion
Yamen Abu Ahmad is a distinguished inventor whose work in RNF4 targeting compounds showcases his dedication to improving healthcare solutions. His contributions are paving the way for future advancements in the treatment of RNF4-related disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile